Study objective: The Third International Consensus Definitions Task Force (SEP-3) proposed revised criteria defining sepsis and septic shock. We seek to evaluate the performance of the SEP-3 definitions for prediction of inhospital mortality in an emergency department (ED) population and compare the performance of the SEP-3 definitions to that of the previous definitions.
INTRODUCTION
In 1992, Bone et al 1 published consensus definitions for sepsis, revolving around the systemic inflammatory response syndrome (SIRS) criteria. The SIRS construct helped to identify an inflammatory response, which in the presence of an infection defined "sepsis." 1, 2 This unified communication in both the clinical and research settings. However, criticism arose around the definitions' being overly sensitive and nonspecific. For example, a young adult with routine streptococcal pharyngitis may exhibit fever and tachycardia, meeting the definition of sepsis; this patient often has no increased risk of severe short-term adverse effects from the infection. During the last 2 decades, many individuals have noted the limitations of SIRS criteria, [3] [4] [5] prompting calls to revisit the definition of sepsis. 6, 7 The Third International Consensus Definitions Task Force (SEP-3) revisited the sepsis definitions and published a set of revised definitions. 8, 9 To aid the effort, research using 2 large data sets guided derivation of criteria to riskstratify patients with infection according to the likelihood of inhospital mortality. The quick Sequential Organ Failure Assessment (qSOFA) score emerged as a tool to identify septic patients at higher risk of short-term death, drawing
Editor's Capsule Summary
What is already known on this topic Many emergency departments (EDs) screen for sepsis to identify patients who would benefit from early intervention. An international consensus group (Third International Consensus Definitions Task Force ) recently proposed new criteria defining sepsis and septic shock, with implications for screening and quality measures.
What question this study addressed
How do test characteristics of the new SEP-3 definitions compare with the original 1992 definitions in predicting all-cause inhospital mortality?
What this study adds to our knowledge Among 7,637 ED patients with suspected infection (4.4% mortality) from 3 previous studies, SEP-3 criteria were less sensitive but more specific at predicting mortality than the older criteria.
How this is relevant to clinical practice
From an emergency medicine perspective, identifying individuals who benefit from early treatment, rather than those who will die, is the key goal of screening. With this caveat, these results could inform the choice of sepsis criteria; the greater sensitivity of older systemic inflammatory response syndrome criteria may be preferred for early clinical screening.
observations from initial features in the emergency department (ED) and other settings. 10 The qSOFA score targets easy bedside application and uses 3 clinical criteria, with each receiving 1 point if present: respiratory rate greater than or equal to 22 breaths/min, altered mental status, and hypotension defined by a systolic blood pressure less than or equal to 100 mm Hg. A qSOFA score of 2 or greater was associated with an increased risk of mortality. The definitions group proposed using a suspected infection plus a qSOFA score greater than or equal to 2 to help identify patients with potential sepsis in the non-ICU setting. The SEP-3 authors state that qSOFA score greater than or equal to 2 should prompt clinicians to investigate for organ dysfunction because these patients may be septic.
The SEP-3 group redefined septic shock as patients with hypotension requiring vasopressor support to maintain a mean arterial pressure of 65 mm Hg and a lactate level greater than 2.0 mmol/L after adequate resuscitation. 8, 11 This definition sought to select patients with a higher acuity by including vasopressors as a criterion along with a biochemical response. This enhances specificity for the most ill septic patients, although the overall effect on care across the sepsis spectrum is unknown.
The SEP-3 authors acknowledge that these new definitions require validation in specific clinical settings, including the ED. We sought to evaluate the performance of the SEP-3 qSOFA criteria and revised septic shock definition in predicting mortality in ED patients with a suspected infection, and to compare the performance of the SEP-3 definitions to the previous 1992 consensus criteria of sepsis, severe sepsis, and septic shock.
MATERIALS AND METHODS
This is a secondary analysis of 3 prospectively collected, observational cohorts of patients with clinically suspected infection. The setting for the first 2 cohorts was a 600-bed urban tertiary care center with approximately 50,000 ED visits per year, and the third cohort was enrolled in an 800-bed, urban, academic, tertiary care hospital with approximately 100,000 patient visits per year. (Table E1 , available online at http://www.annemergmed.com). The institutional review boards of both participating medical centers approved our study. We used the Strengthening the Reporting of Observational Studies in Epidemiology guidelines for reporting this observational study. 12 Each study included subjects aged 18 years or older. To identify patients with suspected infection in the first 2 cohorts, we reviewed all patients with an ED admission diagnosis consistent with infection (ie, pneumonia) or possibly infection related (ie, shortness of breath); the interrater reliability for this approach was excellent (Cohen's k¼0.9). 13 All records with suspected infection underwent a confirmatory review based on ED presentation as documented in the medical decisionmaking portion of the chart. We declared subjects as having a clinically suspected infection if they met any of the following criteria: a documented source of infection, documentation of a clinical diagnosis of infection by the ED clinician, or administration of antibiotics in the ED. We assembled the third cohort of subjects with a standard random sampling methodology, using randomly selected 24-hour periods, equally dispersed over four 3-month blocks, resulting in 182 enrollment days.
14 Inclusion criteria were ED patients aged 18 years or older, hospital admission, and suspected infection, defined by antibiotic administration in the ED. We abstracted ED charts without any subsequent knowledge of the hospital course. For the first 2 cohorts, subject data and outcomes were abstracted manually by trained research assistants, and in the third cohort, subject data were abstracted with a computer program with manual review, augmented by manual abstraction of any missing data and outcomes (Table E1 , available online at http://www.annemergmed.com).
Definitions are provided in Table 1 . We calculated the qSOFA score by assigning patients 1 point for each of the following: systolic blood pressure less than or equal to 100 mm Hg, respiratory rate greater than or equal to 22 breaths/min, or altered mental status documented by the physician, using the most abnormal value during the care interval. 8, 9 We defined septic shock based on the SEP-3 criteria as a vasopressor infusion and a serum lactate concentration greater than or equal to 2.0 mmol/L. 11 We defined sepsis as 2 or more SIRS criteria (pulse rate !90 beats/min, respiratory rate !20 breaths/min, WBC count !12,000 or 4000 cells/mm 3 or bands >10%, and temperature !100.5 F [38.0 C] or 96 F [35.6 C]) plus a suspected infection, using vital signs and laboratory study results obtained at any point during the ED stay. We defined severe sepsis as suspected infection plus organ dysfunction. We used previously reported modified definitions for organ dysfunction: neurologic (altered mental status by history or examination), cardiovascular (systolic blood pressure <90 mm Hg), hematologic (platelets 100,000 cells/mm 3 ), renal (creatinine level >2.0 mg/dL, not known to be chronic), metabolic (lactic acid >4.0 mmol/L), and pulmonary (respiratory rate >20 breaths/min or hypoxemia, defined as pulse oximetry <90% on room air or 95% while breathing supplemental oxygen). 15 We defined septic shock according to the 1992 consensus guidelines as hypotension (systolic blood pressure <90 mm Hg) after fluid resuscitation or the initiation of vasopressor infusion. 1 We used the most abnormal vital signs during the ED stay, so definition criteria could be met at any point during the ED stay. We excluded subjects without documented mental status examinations when assessing qSOFA. Similarly, we excluded patients without a blood lactate level measured when assessing the septic shock definition. The full data needed to assess the 1992 sepsis definitions were not available for the third cohort, so we calculated this portion only, using the first 2 cohorts.
Outcome Measures
The primary outcome was all-cause inhospital mortality, defined as death before hospital discharge.
Primary Data Analysis
We calculated each patient qSOFA score, and we then calculated the sensitivity and specificity of qSOFA score greater than or equal to 2 for inhospital mortality for each cohort and overall data set. Likewise, we calculated the test characteristics for the previous definitions of sepsis (SIRS score !2 plus a suspected infection) and severe sepsis for mortality in the first 2 data sets. We calculated an area under the curve for the qSOFA score to predict mortality in each cohort. As a sensitivity analysis, we recalculated the qSOFA test characteristics when the excluded patients from cohort 3 were included with a presumed normal mental Table 1 . Criteria used to define sepsis, severe sepsis, and septic shock. Renal: creatinine >2.0 mg/dL, not known to be chronic Pulmonary: respiratory rate >20 breaths/min or pulse oximetry <90% on room air or <95% while breathing supplemental oxygen >4 L/min Septic shock Septic shock SepsisDevidence of hypoperfusion Vasopressor requirement to maintain mean arterial pressure >65 and serum lactate >2.0 mmol/L Vasopressor requirement Hypotension after at least 2 L intravenous fluids status. For septic shock, we report the test characteristic for sepsis syndromes defined by the 1992 consensus guidelines and SEP-3 definitions of septic shock for inhospital mortality in the first 2 data sets. When calculating test characteristics for the SEP-3 septic shock definition, we removed subjects without a lactate level measured. As a sensitivity analysis, we recalculated test characteristics after reincluding these patients in the population and compared results. Last, to evaluate whether lactate concentrations would improve the predictive value of the qSOFA score, we performed a sensitivity analysis by adding patients with lactate level greater than 2.0 and 4.0 mmol/L to the SEP-3 sepsis definition. We also calculated the net reclassification improvement to quantify the improvement in risk stratification when including a lactate concentration.
RESULTS
There were a total of 7,754 patients with suspected infection among the 3 eligible ED cohorts. There were 117 patients without a mental status examination who were excluded from the third cohort, leaving 7,637 patients for analysis (Figure 1 ). Among this group, 333 of 7,637 (4.4%; 95% confidence interval [CI] 3.9% to 4.9%) died inhospital. The demographics, comorbid distribution, and rates of adverse outcomes were similar among the 3 cohorts (Table 2) .
Among the combined data sets, 15.9% of patients (95% CI 15.1% to 16.7%) met the proposed SEP-3 sepsis criteria of qSOFA score greater than or equal to 2 in the ED (Table 3 ). The inhospital mortality was 14.2% (12.2% to 16.2%) for patients with a qSOFA score greater than or equal to 2 compared with 2.5% (2.1% to 2.9%) for qSOFA score less than 2. Overall, the sensitivity of qSOFA score greater than or equal to 2 to predict inpatient mortality was 52% (46% to 57%) and specificity was 86% (85% to 87%) ( Table 3 ). The operating test characteristics were similar across the 3 cohorts, supporting the validity of the findings. The sensitivity analysis that included the originally excluded patients from cohort 3 resulted in similar test characteristics (Table E2 , available online at http://www.annemergmed.com). The overall area under the curve for qSOFA was 0.77 (cohort 1 0.79, cohort 2 0.76, and cohort 3 0.76). When the 1992 sepsis criteria are used according to having 2 or more SIRS criteria, 50.2% of subjects (49.0% to 51.4%) met the sepsis definition (Table 3 ). Compared to subjects scored with the qSOFA definition, the 1992 sepsis criteria subjects had a lower overall mortality rate of 6.8% (6.0% to 7.7%), with a higher sensitivity of 83% (79% to 87%) and lower specificity of 50% (49% to 51%) for predicting mortality. We also assessed the 1992 definition for severe sepsis, which was not included in the revised definitions. For severe sepsis, 37.5% of subjects (36.4% to 38.7%) met the 1992 consensus definition, with a mortality rate of 9.7% (8.5% to 10.9%), a 78% sensitivity (73% to 83%), and 64% specificity (63% to 65%). The severe sepsis definition had a higher sensitivity than the qSOFA score, but lower specificity. Compared with the 1992 sepsis definition, sensitivity was similar, but specificity was higher. Table 3 Of the 6,750 subjects in the first 2 cohorts, using qSOFA score greater than or equal to 2 to screen for septic patients instead of greater than or equal to 2 SIRS criteria resulted in 2,385 fewer patients (35%; 34% to 36%) meeting criteria for sepsis. Among the 2,385 patients who had a negative qSOFA score were 93 (28%) of the 333 deaths in the group (Figures 2 and 3) .
For the 4,526 patients with a lactate level available, we assessed the SEP-3 septic shock definition. There were 2.9% of subjects (2.4% to 3.4%) who met the SEP-3 criteria for septic shock, and 22.9% (15.7% to 30.1%) of these died (Table 4) . Overall, the SEP-3 septic shock definition had a sensitivity of 12% (11% to13%) and specificity of 98.4% (98.1% to 98.7%) for mortality when all patients meeting study inclusion criteria were considered. We performed a sensitivity analysis by adding patients with missing lactate measurements and assuming values were normal; the results were similar (Table E3 , available online at http://www.annemergmed.com). There were 4.2% of patients (3.7% to 4.7%) who met the 1992 consensus definition of septic shock. In comparison to the SEP-3 septic shock definition, the 1992 consensus definition had a comparable inhospital mortality rate of 22.2% (17.4% to 27.0%), with a higher sensitivity of 23% (22% to 24%) and similar specificity of 96.6% (96.2% to 97.0%).
To evaluate whether including lactate concentrations would improve the predictive value of the qSOFA score, we performed a sensitivity analysis by adding patients with lactate level greater than 2.0 and 4.0 mmol/L to those meeting the SEP-3 sepsis definition (Table 5) . Adding a lactate level greater than 2.0 mmol/L to the SEP-3 qSOFA score improved the sensitivity of the definition while decreasing the specificity compared with qSOFA score greater than or equal to 2 alone. The net reclassification improvement when we included lactate level greater than 2.0 mmol/L was 11%: 22 of 83 events (29%) correctly moved to an increased risk category and 380 of 2,049 nonevents (18%) incorrectly moved to increased risk category. The net reclassification improvement when we included lactate level greater than 4.0 mmol/L was 9%: 29 of 276 events (11%) correctly increased risk category and 127 of 6,474 nonevents (2%) incorrectly increased risk category.
LIMITATIONS
One limitation to using the SEP-3 approach is the construct of using mortality as a criterion standard for the definition of a disease state. Using mortality to define sepsis or septic shock carries a risk that septic patients will be misclassified as not having the disease. Some patients who may be critically ill with sepsis and manifest all of the pathophysiologic derangements of the disease survive, whereas some who die may not actually have sepsis.
As with any secondary analysis, we collected these data used for another purpose, with the possibility of misclassification bias through incomplete data recording or assessment of covariates. However, those studies targeted the same topic and outcomes, mitigating the risk. Like any clinical trial, threats from missing data exist, especially with mental status examinations (in cohort 3) and lactate measurements. We did analyze the SEP-3 septic shock definition with and without the patients missing measured lactate levels, with essentially equivalent results, again mitigating the concern. We did not prospectively ask that each data element be assessed for the specific purpose of the current study. The omission of qSOFA and organ dysfunction criteria could change the test characteristics for qSOFA and severe sepsis in each cohort.
Our data sets did not include patients who were discharged from the ED, potentially overestimating the specificity of each definition because discharged patients have an inherently lower risk of mortality. The timing of the observation (2003 to 2006) may also have created observations that could vary if applied to a more contemporaneous population. However, the similarity between the mortality rates observed in this study and the SEP-3 derivation study make the likelihood that mortality is overestimated in our study less likely. Last, patients with infection may have been missed in the ED, potentially causing a selection bias if they had different predictors of mortality than those with infection diagnosed in the ED.
DISCUSSION
The consensus sepsis definition efforts initiated more than 25 years ago created a foundation for both the clinical identification and research of sepsis. Because sepsis continues to be defined in the context of mortality risk instead of a defining underlying pathophysiologic mechanism, the challenge of balancing sensitivity and specificity for the prediction of mortality continues with the SEP-3 iteration of the sepsis definitions. Having an approach that fits the needs of both the clinical and research environments is challenging, recognizing that trade-off between sensitivity, specificity, and bedside usability varies according to the setting and application. Table 5 . Incidence, mortality, and test characteristics for the SEP-3 sepsis definition when patients with lactate level greater than 2.0 or 4.0 mmol/L were included in the definition.
Population
Total n Criteria Fulfilled (%) Mortality n (%) Sens (95% CI), % Spec (95% CI), % PPV (95% CI), % NPV (95% CI), %
The SEP-3 definitions of septic shock identified far fewer patients compared with the 1992 consensus definition of septic shock, yet definitions shared a similar mortality rate (23% versus 22%) in our cohorts. Although the SEP-3 criteria for septic shock more narrowly define the target population, this occurs at the trade-off of identifying fewer patients. It is possible that the lower number of patients meeting SEP-3 septic shock criteria limits both the clinical and research utility of these criteria. Similarly, qSOFA is not inherently better or worse than SIRS criteria for identifying patients at risk for sepsis and harm; these tools each embrace different predictive outcomes, one targeting a sensitive approach (SIRS score of 2 or more) suited for early care and allowing fewer missed cases of progression, and another focusing on a specific identification of the higher strata of illness (qSOFA) that can aid later care decisions and pool cohorts with narrow but high risk of death. Depending on the clinical setting, one approach may be superior, although in the ED, early care often seeks avoiding delayed recognition and care to improve overall later outcomes. In contrast to the SEP-3 conclusions, serum lactate levels improved the sensitivity of qSOFA and modestly improved the classification of patients at both the 2 and 4 mmol/L thresholds.
Our data also highlight the utility of the original 1992 "severe sepsis" definition-a term dropped in SEP-3-as a meaningful criteria and risk-stratification approach, especially early in care. Patients meeting severe sepsis criteria had a mortality rate of 9.7% while maintaining a sensitivity (78%) similar to that of the 1992 consensus definition of sepsis, but with a higher specificity. The severe sepsis definition identified more patients with infection who experienced inhospital mortality than qSOFA score greater than or equal to 2, with a specificity of 64%, indicating reasonable utility in identifying sick patients for clinical purposes and research. Compared with a SOFA score greater than or equal to 2 in the SEP-3 validation cohort, which had 68% sensitivity and 67% specificity in the non-ICU setting, the severe sepsis test characteristics likewise compare favorably. Severe sepsis appears to preserve the screening strength of SIRS and the research utility of qSOFA score greater than or equal to 2, and as a prognostic test, we submit that it may be a better definition of sepsis than either the 1992 sepsis definition or proposed SEP-3 qSOFA definition. Additionally, the notion of organ-compromising infection has face validity and overall warrants consideration. 17 We found that both the new SEP-3 and original sepsis definitions stratify ED patients at risk for mortality, albeit with differing performances. Compared with the SIRS-based 1992 consensus sepsis definition, the revised SEP-3 definitions and qSOFA risk assessment tool are generally less sensitive but more specific for mortality. The lower sensitivity and more narrow population meeting criteria should be recognized when either definition is integrated into ED clinical care. Future efforts may consider revisiting the previous severe sepsis definition as an alternative according to its better balance of sensitivity and specificity. Author contributions: DJH, AEJ, and NIS were responsible for the study concept and design. DJH and NIS performed data analysis and drafted the original article. All authors contributed to the interpretation of results, the review and editing of the final article, and the decision to submit the article for publication. DJH, MDH, and NIS created the figures. DJH takes responsibility for the paper as a whole.
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